We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Eupraxia Pharmaceuticals to Present Initial Results from Ongoing Phase 1b Study of EP-104GI for the Treatment of Eosinophilic Esophagitis at Upcoming Digestive Disease Week Annual Meeting...
Eupraxia Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update Canada NewsWire VICTORIA, BC, May 8, 2024 Eupraxia common shares now listed on the Nasdaq...
Eupraxia Pharmaceuticals Announces Gastrointestinal Clinical Advisory Board PR Newswire VICTORIA, BC, May 2, 2024 --Advisory Board to Provide Guidance for Company's Eosinophilic Esophagitis...
Eupraxia Pharmaceuticals Announces Upcoming Presentations at the Osteoarthritis Research Society International World Congress 2024 Canada NewsWire VICTORIA, BC, April 11, 2024 VICTORIA, BC, April...
Eupraxia Pharmaceuticals To Present at Bloom Burton & Co. Healthcare Investor Conference Canada NewsWire VICTORIA, BC, April 8, 2024 VICTORIA, BC, April 8, 2024 /CNW/ - Eupraxia...
Eupraxia Pharmaceuticals Begins Trading on Nasdaq Today PR Newswire VICTORIA, BC, April 5, 2024 VICTORIA, BC, April 5, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or...
Eupraxia Pharmaceuticals to Begin Trading on Nasdaq on April 5, 2024 Canada NewsWire VICTORIA, BC, April 3, 2024 Company's Listing Application Approved by Nasdaq VICTORIA, BC, April 3, 2024...
Eupraxia Pharmaceuticals Reports Fourth Quarter and 2023 Financial Results Canada NewsWire VICTORIA, BC, April 1, 2024 VICTORIA, BC, April 1, 2024 /CNW/ - Eupraxia Pharmaceuticals Inc...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.01 | 0.253164556962 | 3.95 | 4.1 | 3.93 | 30156 | 3.98959092 | CS |
4 | 0.33 | 9.09090909091 | 3.63 | 4.12 | 3.61 | 23904 | 3.93990251 | CS |
12 | -3.17 | -44.4600280505 | 7.13 | 7.22 | 3.45 | 66709 | 4.1459176 | CS |
26 | -2.54 | -39.0769230769 | 6.5 | 7.64 | 3.45 | 41552 | 4.64405242 | CS |
52 | -2.94 | -42.6086956522 | 6.9 | 9.1 | 3.45 | 36606 | 5.80357372 | CS |
156 | -0.68 | -14.6551724138 | 4.64 | 9.1 | 0.8 | 26559 | 4.18434935 | CS |
260 | -3.79 | -48.9032258065 | 7.75 | 9.1 | 0.8 | 26362 | 4.27738298 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions